It is conceivable that additional mutation(s) in tumor suppressor genes, such as p53, is required to drive the tumorigenic pathways in ERαd/d ovaries to rapidly progressing ovarian carcinoma, which will culminate in metastasis. The gene discussed is TP53; the disease is ovarian carcinoma.